ArticleKidney international2011

Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients.

Vimal K Derebail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.